Trial site
Toulouse
- 17running trials
- 14closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Familial hypercholesterolaemia3 trials
- Metastatic breast cancer3 trials
- Coronary artery disease2 trials
- Hidradenitis suppurativa2 trials
- Multiple sclerosis2 trials
- Myelodysplastic syndromes2 trials
- Prostate cancer2 trials
- Stroke2 trials
- Acute myeloid leukaemia1 trial
- Alzheimer disease1 trial
- Chronic spontaneous urticaria1 trial
- and 9 more
- Phase
- Phase 315 trials
- Phase 26 trials
- Phase 13 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Active, not recruiting11 trials
- Completed9 trials
- Recruiting6 trials
- Terminated5 trials
- Lead sponsor
- Novartis Pharmaceuticals31 trials
Running trials
Recruiting
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Active, not recruiting
Recruiting
Active, not recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple sclerosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Completed
Terminated
Terminated
Completed
Completed
Terminated
Completed
Terminated
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 15 Nov 2026